AVORO CAPITAL ADVISORS LLC 13D/13G Filings for Krystal Biotech, Inc. (KRYS)

AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Krystal Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
09:25 am
Purchase		 2023-12-31 13G Krystal Biotech, Inc.
KRYS		 AVORO CAPITAL ADVISORS LLC 2,565,555
9.100%		 1,155,555increase
(+81.95%)		 Filing
2023-02-14
09:33 am
Purchase		 2022-12-31 13G Krystal Biotech, Inc.
KRYS		 AVORO CAPITAL ADVISORS LLC 1,410,000
5.500%		 1,410,000increase
(New Position)		 Filing